Orlance
Chemicals & Related Products · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1124 Columbia St Ste 300, Seattle, Washi...Phone Number
(206) 792-5510Website
www.orlance.comRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Orlance
Orlance specializes in the MACH-1 epidermal formulation and delivery platform, which focuses on precise, localized powdered vaccines and immunotherapies. Their innovative technology allows for rapid vaccine production without cold chain requirements, significantly reducing vaccine doses and enhancing immune responses. The company is currently developing a universal influenza vaccine and other immunotherapy assets, with plans to initiate clinical trials in the near future. Orlance is actively seeking partners and funding to expand its portfolio and advance its vaccine technologies.Explore more
Popular SearchesOrlance IncOrlance Co IncSIC Code 28,283NAICS Code 32,325Show moreOrlance Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orlance your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Orlance has new funding data
Website visits: Recent activity has been detected on your website
Check out if Orlance is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Orlance
Product Launch: Get notified when Orlance launches new products
Earning: See what the market has to say on Orlance recently announced quarterly report
Orlance, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Orlance had a recent Job posting/layoffs
Check if Orlance has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Orlance
Compare insights from companies similar to Orlance, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orlance is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orlance is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orlance.
Orlance Tech Stack
A closer look at the technologies used by Orlance
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Medical Research, Clinical Operations, Operations
Funding
Project
Spending/Investment
Orlance News & Media
Orlance Inc. Awarded Pivotal $3M NIH SBIR Grant for Advancing MACH-1™ Needle-Free, Powdered Universal Influenza Vaccine to the Clinic
SEATTLE, Nov. 28, 2023 /PRNewswire/ -- Orlance, Inc., a Seattle biotech developing next-generation DNA and RNA vaccines and therapeutics, has been awarded a three-year $3M National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant to advance its...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orlance
Sign Up For FreeTo access detailed company insights
Orlance specializes in the MACH-1 epidermal formulation and delivery platform, which focuses on precise, localized powdered vaccines and immunotherapies. Their innovative technology allows for rapid vaccine production without cold chain requirements, significantly reducing vaccine doses and enhancing immune responses. The company is currently devel... Read More
